The co-occurrence of MYC rearrangements with BCL2 and/or BCL6 rearrangements, known previously as “double-hit” or “triple-hit” lymphomas, now known as High-Grade B-Cell Lymphoma (HGBCL), is associated with very poor prognosis and resistance to conventional treatments (142). This evidence concerns the gene MYC and lymphoma.